Kintor Pharmaceutical Statistics
Total Valuation
KNTPF has a market cap or net worth of 67.52 million. The enterprise value is 65.37 million.
| Market Cap | 67.52M |
| Enterprise Value | 65.37M |
Important Dates
The next estimated earnings date is Monday, May 26, 2025.
| Earnings Date | May 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.39% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 359.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 98.57 |
| PB Ratio | 1.68 |
| P/TBV Ratio | 3.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.07 |
| EV / Sales | 95.32 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.03, with a Debt / Equity ratio of 0.45.
| Current Ratio | 1.03 |
| Quick Ratio | 0.99 |
| Debt / Equity | 0.45 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -16.13 |
Financial Efficiency
Return on equity (ROE) is -41.29% and return on invested capital (ROIC) is -16.42%.
| Return on Equity (ROE) | -41.29% |
| Return on Assets (ROA) | -13.51% |
| Return on Invested Capital (ROIC) | -16.42% |
| Return on Capital Employed (ROCE) | -42.94% |
| Revenue Per Employee | 4,077 |
| Profits Per Employee | -126,640 |
| Employee Count | 168 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +77.40% in the last 52 weeks. The beta is -0.10, so KNTPF's price volatility has been lower than the market average.
| Beta (5Y) | -0.10 |
| 52-Week Price Change | +77.40% |
| 50-Day Moving Average | 0.33 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 45.22 |
| Average Volume (20 Days) | 5,356 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KNTPF had revenue of 685,016 and -21.28 million in losses. Loss per share was -0.05.
| Revenue | 685,016 |
| Gross Profit | -648,025 |
| Operating Income | -20.50M |
| Pretax Income | -21.27M |
| Net Income | -21.28M |
| EBITDA | -18.68M |
| EBIT | -20.50M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 20.37 million in cash and 18.22 million in debt, giving a net cash position of 2.15 million.
| Cash & Cash Equivalents | 20.37M |
| Total Debt | 18.22M |
| Net Cash | 2.15M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 40.29M |
| Book Value Per Share | 0.09 |
| Working Capital | 692,003 |
Cash Flow
| Operating Cash Flow | -27.27M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | -94.60% |
| Operating Margin | -2,992.26% |
| Pretax Margin | -3,105.48% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KNTPF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.39% |
| Shareholder Yield | -0.39% |
| Earnings Yield | -31.51% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |